Skip to main content

Table 3 Proportion of HIV, HCV, and HBV seropositive in relation to participants’ characteristics

From: High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania

VariablesHIVHCVHBV
Pos (%)p-valuePos (%)p-valuePos(%)p-value
Age group (yrs) 0.89 0.73 0.15
 < 3935(33.3) 54(51.4) 11 (10.5) 
 ≥ 3939(34.2) 56(49.1) 6 (5.3) 
Sex 0.13 0.26 0.38
 Male60(36.6) 86(52.4) 11(6.7) 
 Female14(25.5) 24(43.6) 6(10.9) 
Marital status 0.01 0.25 0.39
 Unmarried36(27.1) 63(47.4) 12(9.0) 
 Married38(44.2) 47(54.7) 5 (5.8) 
Education level 0.33 0.74 0.08
 Low education43(31.4) 70(51.1) 14 (10.2) 
 High education31(37.8) 40(48.8) 3 (3.7) 
Occupation 0.39 0.58 0.98
 Unemployed37(36.3) 55(53.9) 11(10.8) 
 Employed20(37.0) 26(48.1) 6(11.1) 
 Business17(27.0) 29(46.0) 0 (0.0) 
Monthly income (USD) 0.17 0.63 0.51
 ≤ $4547(37.6) 61(48.8) 11 (8.8) 
 > $4527(28.7) 49(52.1) 6 (6.4) 
Duration of injection 0.18 0.01 0.053
 ≤ 3 years46(30.9) 66(44.3) 8 (5.4) 
 > 3 years28(40.0) 44(62.9) 9 (12.9) 
Frequency of injection per day (last 6 months) 0.76 0.48 0.12
 ≤ 3 times14(31.8) 20(55.5) 6(13.6) 
 > 3 times60(34.3) 90(51.4) 11 (6.3) 
Needle sharing (last 6 months) 0.03 0.84 0.59
 No31 (27.0) 57(49.6) 10(8.7) 
 Yes43(41.3) 53(51.0) 7 (6.7) 
Condom use (last 6 months) 0.02 0.004 0.39
 Never/irregular46(41.1) 67(59.8) 7 (6.2) 
 Always28(26.2) 43(40.2) 10 (9.3) 
  1. Key: Pos Positive
\